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Abstract: 
Adipose-derived stem cells (ASCs) have received considerable attention in oncology 
because of the known direct link between obesity and cancer as well as the use of ASCs 
in reconstructive surgery after tumor ablation. Previous studies have documented how 
cancer cells commandeer ASCs to support their survival by altering extracellular matrix 
(ECM) composition and stiffness, migration, and metastasis. This study focused on 
delineating the effects of ASCs and adipocytes on the self-renewal of stem/progenitor 
cells and hierarchy of breast epithelial cells. The immortalized breast epithelial cell line 
MCF10A, ductal carcinoma in situ (DCIS) cell lines MCF10DCIS.com and SUM225, 
and MCF10A overexpressing SRC oncogene were examined using a mammosphere 
assay and flow cytometry for the effects of ASCs on their self-renewal and stem-luminal 
progenitor-differentiated cell surface marker profiles. Interestingly, ASCs promoted the 
self-renewal of all cell types except SUM225. ASC co-culture or treatment with ASC 
conditioned media (CM) altered the number of CD49fhigh/EpCAMlow basal/stem-like and 
CD49fmedium/EpCAMmedium luminal progenitor cells. Among multiple factors secreted by 
ASCs, IFNγ and HGF displayed unique actions on epithelial cell hierarchy. IFNγ 
increased stem/progenitor-like cells while simultaneously reducing the size of 
mammospheres, whereas HGF increased the size of mammospheres with an 
accompanying increase in luminal progenitor cells. ASCs expressed higher levels of HGF, 
whereas adipocytes expressed higher levels of IFNγ. Since luminal progenitor cells are 
believed to be prone for transformation, IFNγ and HGF expression status of ASCs may 
influence susceptibility for developing breast cancer as well as on outcomes of 
autologous fat transplantation on residual/dormant tumor cells.  
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Implications: This study suggests that the ratio of adipose-derived stem cells to 
adipocytes influences cancer cell hierarchy, which may impact incidence and progression. 
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Introduction: 
Adipose stem cells (ASCs) are increasingly being used for aesthetic and 
reconstructive surgery in multiple surgical disciplines (1-3). Their main utility lies in the 
repair of soft tissue contour deficits either as a result of aging (aesthetic) or tumor 
removal, trauma, and congenital malformations (reconstructive). While their use in 
cosmetic surgery is less controversial, there are some lingering doubts about their safety 
when used at sites of tumor extirpation. Additionally, injection of fat into hormonally 
sensitive sites such as the breast could carry long-term consequences. Long-term follow 
up data in these patients are still not available to ascertain the safety of ASCs in these 
patients. Nonetheless, it is important to investigate the effects of ASCs and adipocytes on 
cancer cells because of the established link between obesity and cancer (4). A recent 
review in Cancer Research identified 37 articles that investigated the influence of ASCs 
on cancer progression and metastases (5). ASC-derived factors such as Vascular 
Endothelial Growth Factor, Interleukin 6 (IL-6), IL-8, Tumor Necrosis Factor Alpha 
(TNFα), Hepatocyte Growth Factor (HGF), Leptin, and Insulin-like growth factor (IGF) 
are suggested to promote angiogenesis, inflammation, cell proliferation, and hypoxia in 
the tumor microenvironment (5-7). Reciprocally, breast tumor cells promote 
transdifferentiation of ASCs into cancer-associated fibroblasts, which enhance tissue 
stiffness (8,9). 
In contrast to ASCs, the role of adipocytes in cancer progression remains 
controversial. Many reports indicated pro-tumor growth effect including adipocyte-
mediated induction of epithelial to mesenchymal transition (EMT) and resistance to 
ERBB2-targeted therapy (10,11).  The adipokine Lipocalin2 secreted by adipocytes 
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linked obesity to breast cancer progression (12). However, a recent study showed reduced 
proliferation of breast cancer cells that are in direct contact with neighboring adipocytes 
(13).  
There are several gaps in our understanding of the role of ASCs and adipocytes on 
breast cancer. The first, do normal and tumor cells respond similarly to ASCs? Second, to 
what extent do ASCs alter stem-luminal progenitor-differentiated cell hierarchy in normal 
and cancer breast epithelial cells? Addressing this question is critical because most breast 
cancers are believed to originate from luminal progenitor cells (14,15). Third, do ASCs 
and adipocytes have distinct effects on normal and tumor cells and if so, can these 
differences be attributed to ASCs and adipocytes-enriched chemokines/cytokines? 
To address the above questions, we utilized an in vitro system where we measured 
the effects of conditioned medium (CM) from ASCs and ASC derived adipocytes on 
stem-luminal progenitor-differentiated cell hierarchy under growth conditions that 
promote self-renewal as well as differentiation of stem cells. Spontaneously immortalized 
breast epithelial cell line MCF10A, MCF10A cells with enhanced EMT characteristics 
due to overexpression of SLUG (MCF10A-SLUG) (16), a MCF10A derivative that 
generates ductal carcinoma in situ (MCF10DCIS.com) (17) and MCF10A cells 
transformed by the SRC oncogene (MCF10A-SRC) were tested (18). We demonstrate 
that ASCs and adipocytes have distinct effects on the hierarchy of immortalized and 
transformed breast epithelial cells. HGF, secreted at higher levels by ASCs, and 
interferon gamma (IFNγ), secreted at higher levels by adipocytes, altered breast stem-
luminal progenitor-differentiated cell profiles. We propose that the inter-individual 
differences in the ratio of ASCs to adipocytes in fat tissue or the ability of ASCs to 
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differentiate into adipocytes could influence the rate of differentiation of breast epithelial 
cells with ultimate impact on breast cancer incidence and progression. 
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Materials and Methods: 
Cell lines and mammosphere assay: MCF10A and MCF10DCIS.com cell lines were 
purchased from ATCC. MCF10A cells overexpressing SLUG have been described (16). 
Dr. Kevin Struhl (Harvard Medical School) provided MCF10A cells overexpressing SRC 
oncogene linked to the ligand binding domain of estrogen receptor (MCF10A-SRC) and 
these cells have been described previously (18). SUM225 cells were purchased from 
Asterand (Detroit, MI) and maintained in media recommended by Asterand. Primary 
ASCs were isolated from abdomen, hips, axilla and/or flank and cultured as previously 
described (19). SUM225 and MCF10DCIS.com cells were purchased for this project 
alone and were cultured for the first time for this study. MCF10A cells have been 
authenticated within last two years using STR Systems for Cell line identification (DNA 
Diagnosis Center, Fairfield, OH). Supplementary Table 1 (Table S1) provides details of 
sites of fat tissue collection, age, and BMI of individuals from whom ASCs were 
collected. All procedures of collecting human adipose tissue were approved by the 
Indiana University School of Medicine Institutional Review Board. All samples were 
from females. These ASCs have been characterized by flow cytometry for cell surface 
markers and for osteogenesis and adipogenesis as described previously (19,20). ASCs 
were subjected to adipocyte differentiation by culturing in adipogenic differentiation 
media (21). Conditioned medium (CM) from confluent cultures was used. The 
mammosphere assay has been described previously (22). Briefly, 5000 cells were plated 
on ultra-low adherent six well plates in MammoCult media from Stemcell Technologies 
(Vancouver, Canada). In co-culture experiments, equal number of ASCs and Green 
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Fluorescent Protein (GFP)-labeled MCF10A or MCF10A-SRC cells was plated. 
Mammospheres were imaged and/or subjected to flow cytometry 6-10 days after plating. 
Cytokines/chemokines/growth factors, Antibodies and flow cytometry: Human cytokine 
array panel A (R&D systems, Minneapolis, MN, catalogue #ARY005) was used to 
measure secreted factors in CMs of ASCs and adipocytes. Assays were done as per 
instructions from the manufacturer. HGF, IFNγ, CXCL1, SERPINE1, IL-17E, IL23, and 
CD40L were purchased from R&D Systems or Peprotech, Inc (Rocky Hills, NJ). 
Concentrations of cytokines/chemokines/growth factors used in mammosphere assays are 
indicated in figure legends. Antibodies against CD49f, CD44, CD24 and EpCAM used 
for flow cytometry have been described in our recent publication (23). Mammospheres 
were collected, washed and exposed briefly to trypsin to obtain single cell suspensions. 
Cells were stained with indicated antibodies and subjected to flow cytometry. The 
percentage of cells in each quadrant or region is presented in the manuscript. For 2D 
cultures, cells were treated with indicated cytokines/chemokines/growth factors for 48 
hours, collected by trypsinization, and subjected to flow cytometry.  
RNA isolation and quantitative reverse transcription polymerase chain reaction (qRT-
PCR): RNeasy kit from Qiagen (Redwood City, CA) was used to isolate total RNA. qRT-
PCR was performed as described previously and expression levels were normalized to 
GAPDH (22). Primers used were: HGF Forward 5’-TGG GAA CCA GAT GCA AGT 
AAG-3’, Reverse 5’-AAT GAG TGG ATT TCC CGT GTA G-3’; IFNγ Forward 5’-CCC 
ATG GGT TGT GTG TTT ATT T-3’, Reverse 5’-AAA CCG GCA GTA ACT GGA 
TAG-3’ and GAPDH 5’-GGT GTG AAC CAT GAG AAG TAT GA-3’, Reverse 5’-
GAG TCC TTC CAC GAT ACC AAA G-3’. 
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Statistical analysis: All data presented are mean ±standard deviation from 2-6 
experiments. In experiments with similar trends but with experimental variability, 
experiments with least variability were selected for statistical analysis. Student t test was 
used to measure the statistical significance between measurements (Graphpad.com).  
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Results:  
ASCs enhance self-renewal of breast epithelial cells  
The mammosphere assay is used routinely as a surrogate assay to measure self-renewal; 
previous studies in neurosphere cultures have shown that the size of the spheres indicates 
the extent of self-renewal (24,25). We used this assay to determine the effect of ASCs on 
self-renewal of immortalized and transformed breast epithelial cells. Since breast 
epithelial cells are marked with GFP, spheres formed by breast epithelial cells and ASCs 
could be easily distinguished by fluorescent microscopy. MCF10A cells formed smaller 
spheres and the size of the spheres were much larger when co-cultured with ASCs 
(Figure 1A). ASCs from three different individuals gave similar results. ASCs did not 
have consistent effects on number of spheres but the sphere size increased. For example, 
ASC #4 increased the size of spheres from 73 x 40 micrometer to 111 x 80 micrometer. 
Furthermore, ASCs increased the size of the MCF10A-SRC-derived mammospheres 
(from 80 x 69 micrometer to 170 x 144 micrometer). We next determined whether CM 
from ASCs similarly influenced the size of mammospheres. Indeed, CM treatment alone 
was sufficient to increase the size of mammospheres (Figure 1B). Thus, transacting 
soluble factors from ASCs are sufficient to enhance the self-renewal of immortalized and 
transformed breast epithelial cells. 
ASCs expand basal/luminal progenitor cell population of MCF10A cells 
Breast epithelial cells with basal/stem-like, luminal progenitor, and non-
clonogenic/differentiated characteristics display CD49f+/EpCAM-, CD49f+/EpCAM+, 
and CD49f-/EpCAM+ cell surface marker profile, respectively (26,27). We used these 
two marker combinations to determine the effects of ASCs on phenotype of cells in the 
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mammospheres. ASCs themselves do not stain for CD49f or EpCAM (data not shown). 
Nonetheless, we examined the phenotype of all cells in the co-culture or cells gated for 
GFP positivity. ASC co-culture increased the number of CD49f+/EpCAM+ MCF10A 
cells (Figure 2A). Results of two independent co-culture experiments are shown in Figure 
2B. ASC CM also increased the number of CD49f+/EpCAM+ cells (Figure 2A).  
 We recently reported that the EMT-associated gene SLUG increases MCF10A 
stemness (16). Since EMT is linked to various aspects of cancer progression including 
drug resistance (28,29), we then examined whether ASCs can further alter the phenotype 
of MCF10A-SLUG cells. ASC CM increased the size of MCF10A-SLUG-derived 
mammospheres with corresponding elevation in number of cells with luminal progenitor 
phenotype (Figure 2C).  
Transformed cells respond differently to ASC and adipocyte CMs 
 To determine whether ASCs and adipocytes have different effects on breast 
epithelial cells, we obtained ASCs from three additional individuals and collected CMs 
from undifferentiated and adipocyte-differentiated ASCs. CMs from ASCs were more 
effective than CMs from adipocytes in increasing the size of MCF10A-derived 
mammospheres (Figure 3A). ASC CM (all three) but not adipocyte CM (one out of three) 
increased the number of CD49f+/EpCAM- cells in the mammospheres (Figure 3B and C). 
Note that these three samples were obtained from individuals with higher BMI and ASCs 
from these individuals increased stem rather than luminal progenitor cells (Compare 
Figures 2 and 3). Thus, there may be inter-individual variation in the effect of ASCs on 
stem/progenitor composition of breast epithelial cells.   
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 CD44+/CD24- cells are considered breast cancer stem cells and CD44 expression 
alone is linked to undifferentiated status of breast epithelial cells (27,30). We used these 
two markers to characterize the mammospheres for undifferentiated cells. ASC CM 
increased CD44+/CD24- cells compared with adipocyte CMs (Figure 3B and D). 
Because of experimental variability, representative data are shown in this figure. Thus, 
based on expression pattern of two sets of markers, we conclude that ASCs increase the 
number of either luminal progenitor or basal/stem-like cells when cells are grown under 
mammosphere growth conditions. 
 We next determined the influence of CM from ASCs and adipocytes on MCF10A 
cells grown under 2D culture. Unlike in mammosphere growth condition, neither ASC 
CM nor adipocyte CM influenced the phenotype of MCF10A cells (Figure 3E and F).  
To determine whether transformed and non-transformed cells respond differently 
to ASCs and adipocytes, we next investigated the effects of CM from ASCs and 
adipocytes on MCF10A-SRC cells. In contrast to MCF10A cells, both ASCs and 
adipocyte CM increased the size of MCF10A-SRC derived mammospheres (Figure 4A).  
Flow cytometry of mammospheres revealed that CM from both ASCs and adipocytes 
increased the number of luminal progenitor cells (Figure 4B). Please note that ASC CM 
and adipocyte CM had minimum effects on CD44 and CD24 status under mammosphere 
growth condition (Figure 4B). However, under 2D condition, adipocyte CM but not ASC 
CM increased the number of CD44+/CD24- undifferentiated cancer stem-like cells while 
neither CM had an effect on CD49f/EpCAM status (Figure 4C and D). Thus, transformed 
status and culture conditions determine the influence of ASCs and adipocytes on breast 
epithelial cells. 
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ASCs increase the number of luminal progenitors in ductal carcinoma in situ (DCIS) 
cells  
Identifying features of DCIS that can predict the potential to re-emerge as 
invasive cancer has been a great challenge and is an unmet need (31). Clinically, 
increased BMI is associated with ER-positivity and radiographic abnormalities of DCIS 
(32). To determine whether ASCs influence the self-renewal and differentiation status of 
DCIS, we examined two cell lines that are routinely used to study DCIS. 
MCF10DCIS.com cells give rise to DCIS like lesions when implanted subcutaneously 
into nude mice (17). ASC but not adipocyte CM increased the size of mammospheres 
(Figure 5A). ASC CM increased the number of luminal progenitor cells 
(CD49fhigh/EpCAM+) and cancer stem like undifferentiated (CD44+/CD24-) cells 
(Figure 5B and C). Adipocyte CM was ineffective in altering differentiation/stem status 
of these cells (Figure 5D).  
The cell line SUM225 is also being used as a model for DCIS (33). Unlike all 
other cell types tested, SUM225 cells were unresponsive to ASC and adipocyte CM both 
with respect to mammosphere formation and changes in the marker profiles (Figure S1). 
SUM225 cells overexpress ERBB2 oncogene and it is possible that ASCs and ERBB2 
activate overlapping signaling pathways to alter differentiation status of breast epithelial 
cells.  
Individual variation in soluble factors secreted by ASCs 
 We performed cytokine array analysis of ASC CM (two patients) and adipocyte 
CM (one patient) to identify secreted factors that may alter differentiation of breast 
epithelial cells. Factors identified include CCL2, CD40L, CD54, CSF2, CXCL1, 
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CXCL11, IFNγ, IL-6, IL-8, IL-16, IL17E, IL-23, and SERPINE1 (Figure S2). CD40L, 
CSF2, IFNγ, IL-23, and SERPINE1 were common between ASCs of two patients. 
Differentiation into adipocytes reduced the levels of these factors with the exception of 
IL-23.  
HGF and IFNγ alter mammosphere size and/or differentiation status of breast epithelial 
cells 
We systematically analyzed the effects of recombinant proteins corresponding to 
several ASC secreted factors for mammosphere formation and/or alteration in 
stem/progenitors in mammospheres. Only positive results are described below. We 
included HGF in this assay because previous studies have shown an important role of 
ASC-derived HGF on invasion of breast cancer cells (6). HGF and IFNγ consistently 
increased the size of mammospheres derived from MCF10DCIS.com cells (Figure 6A). 
However, in transformed MCF10A-SRC cells, HGF increased but IFNγ reduced the size 
of mammospheres (Figure S3A). None of the other factors had an effect on the size of 
mammospheres (data not shown). In MCF10A cells, HGF had no effect on the size of the 
mammospheres, whereas IFNγ reduced the size of mammospheres (Figure S4A). 
We next determined the phenotypic effect of HGF and IFNγ on cells in the 
mammosphere. Similar to the effects of ASC CM, HGF altered CD49flow/EpCAM+ and 
CD49f+/EpCAM+ ratio in favor of elevated CD49f+/EpCAM+ progenitor 
MCF10DCIS.com cells (Figure 6B and C). Similar effects were noted with IFNγ, 
although there was marked experimental variability. Note that neither HGF nor IFNγ 
altered CD44/CD24 staining pattern in MCF10DCIS.com-derived mammospheres, 
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although overall CD44 staining intensity was higher in HGF-treated and lower in IFNγ-
treated mammospheres.  
HGF and IFNγ displayed distinct effects on the phenotype of MCF10A-SRC-
derived mammospheres. While HGF increased CD49f+/EpCAM+ luminal progenitor 
cells, IFNγ increased the number of stem cells (Figure S3B). In fact, IFNγ increased the 
intensity of CD49f staining, whereas HGF increased EpCAM staining intensity (Figure 
S3C). In case of MCF10A cells, HGF increased the number of CD44+/CD24- cells 
similar to ASC CM albeit weakly (Figure S4B). IFNγ increased the number of 
CD49f+/EpCAM+ progenitor and CD49f+/EpCAM- stem/basal cells (Figure S4C and D). 
It appears that IFNγ blocked differentiation of stem/progenitor cells as mammospheres 
had no CD49f-/EpCAM+ cells. These results show that HGF and IFNγ distinctly alter the 
stem or progenitor cell composition of immortalized, DCIS, and invasive cancer cells. 
Since the effects of ASC CM and HGF/IFNγ overlapped partially, it appears that 
combined effects of multiple factors in ASC CM contribute to mammosphere expansion.  
 To determine whether there is any relationship between HGF and IFNγ expression 
in ASCs and adipocytes, we measured their mRNA levels by qRT-PCR. Differentiation 
of ASC to adipocytes caused significant drop in HGF levels with concomitant increase in 
IFNγ levels (Figure 6D). 
HGF/IFNγ mRNA ratio in the breast tumor microenvironment predicts outcome in 
patients with ER- or PR- breast cancers 
 Since adipocyte differentiation altered the ratio between HGF and IFNγ, we next 
determined whether the ratio between these two factors within the breast cancer 
environment has any prognostic value using a tool we developed recently (34). 
on April 23, 2016. © 2016 American Association for Cancer Research. mcr.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on April 20, 2016; DOI: 10.1158/1541-7786.MCR-16-0055 
 17
HGF/IFNγ ratio can be a surrogate for ASCs and adipocytes composition in the tumor 
microenvironment. cBioportal analysis showed a tendency of mutual exclusivity in their 
expression in breast cancer (data not shown). In the TCGA dataset, elevated HGF/IFNγ 
ratio was associated with poor overall survival among patients with Estrogen Receptor 
(ER)-negative and Progesterone Receptor (PR)-negative but not ER-positive and PR-
positive breast cancers (Figure S5). Since ER-negative and PR-negative breast cancers 
are associated with poor outcome, ASC/adipocyte ratio may influence outcome in 
patients with these highly aggressive forms of breast cancer. 
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Discussion: 
Multiple mechanisms have been proposed to link adiposity with cancer incidence 
and/or outcome (4). Several pro-tumorigenic and anti-tumorigenic factors have been 
identified in both ASCs and adipocytes. For example, adipocyte secreted leptin and 
adiponectin have opposing biological effects in the normal breast, which impacts breast 
cancer susceptibility (35). Xenograft models have shown that the type of adipocytes, 
particularly beige/brown adipocytes, influence breast tumor development and progression 
(36).  The majority of mechanistic studies on the effects of adiposity on breast cancer 
have focused on leptin signaling, including leptin-STAT3-G9a axis, leptin-induced EMT, 
and angiogenesis (37-39). Several other soluble factors from ASCs have been implicated 
in this process including VEGF, IL-8, IGF, and HGF (5). A recent “meta PubMed” 
search identified 37 studies that have linked ASCs to cancer progression with the 
majority indicating unfavorable effects (5). Concurrently, breast cancer-derived factors 
themselves have been shown to alter plasticity and differentiation capacity of ASCs and 
promote their differentiation into cancer-associated fibroblasts (8,40).  
Adiposity has not only been linked to cancer incidence but also to the molecular 
subtypes of breast cancer (4). For example, in premenopausal women, adiposity is 
associated with ~10% risk reduction in less aggressive ER+/PR+ breast cancers but ~80% 
increase in risk of aggressive ER-/PR- and triple negative breast cancers. In post-
menopausal women, adiposity increases risk for both ER+/PR+ and ER-/PR- breast 
cancers. While multiple studies have independently analyzed the effects of ASCs and 
adipocytes, there has not been a comprehensive study comparing the effects of ASCs and 
adipocytes on “progression series” of breast epithelial cells, particularly in the context of 
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epithelial cell hierarchy. Our study has addressed this issue by measuring the effects of 
ASCs and their differentiated counterparts on immortalized breast epithelial cells, non-
invasive cancer cells representing DCIS, and invasive breast cancer cells. While ASCs 
were more effective than adipocytes in altering stem/progenitor cell composition of 
immortalized and non-invasive cancer cells, adipocytes were as effective as ASCs in 
altering progenitor/stem cell composition of invasive cancer cells. Please note that we did 
not observe a consistent increase in the number of mammospheres by any treatment 
suggesting that ASCs do not cause dedifferentiation of differentiated cells to 
stem/progenitor cells. Instead, ASCs or adipocytes have an effect on the self-renewal or 
expansion of existing pool of stem/progenitor cells. We also observed a lack of effect of 
ASC or adipocytes on a DCIS cell line with ERBB2 amplification suggesting that certain 
cancer-associated genomic events activate signaling cascades that overlap with adiposity-
driven signals. Additional studies with multiple models are needed to identify the cancer 
subtypes that are not impacted by adiposity or ASC/adipocyte ratio.  
The differential effect of ASC and adipocyte CM on non-invasive and invasive 
breast cancer cells is intriguing. We found ASC CM containing more soluble factors than 
adipocyte CM with very few being common to both. It is interesting that both ASC and 
adipocyte CM secrete IL-23, a cytokine that suppresses immune response during tumor 
initiation, growth, and metastasis (41,42).  Therefore, ASCs and adipocytes may play a 
similar role in blocking host immune response to tumor. Additionally, adiposity may 
have an impact on response to recently developed immune checkpoint therapy for cancer 
(43). 
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While the role of ASC-derived HGF on breast cancer cells has been studied (6), 
its influence on breast epithelial cell differentiation is unknown. Our studies indicate the 
ability of HGF to expand luminal progenitor cell population. Luminal progenitor cells in 
breast epithelial cell hierarchy are believed to be the most susceptible cell population for 
transformation and ASC composition in the breast may determine the proportion of 
cancer susceptible subpopulations of breast epithelial cells (14). Although HGF-mediated 
signaling events that promote expansion of luminal progenitor cells are yet to be 
elucidated, HGF-cMET axis has been shown to activate β-Catenin, which is a critical 
transcription factor in breast stem/progenitor cells (6,44).  
We noticed unique effects of IFNγ on breast epithelial and cancer cells. Although 
we did not observe a uniform effect of IFNγ on the size of mammospheres, it promoted 
the accumulation of stem-like or progenitor cells and possibly blocked differentiation of 
MCF10A cells. It is unclear at present whether IFNγ selectively kills differentiated  cells, 
promotes dedifferentiation of differentiated cells, or blocks differentiation at progenitor 
cell state. Nonetheless, the observed effect of IFNγ is significant because its expression is 
induced upon differentiation of ASCs to adipocytes (Figure 6) and its higher expression 
compared to HGF is associated with favorable outcome in ER- and PR- breast cancer 
patients (Figure S5). It is possible that IFNγ promotes dormancy of tumor cells by 
inhibiting their cell cycle progression and maintaining them in G0/G1 stem-like state. 
IFNγ has previously been shown to inhibit cell cycle progression of mammary epithelial 
cells by inducing the expression of p27kip1 (45). A recent study has shown stem cell-like 
properties of p27kip1-positive breast epithelial cells (46). Collectively, our studies 
suggest that ASC/adipocyte composition in the breast microenvironment determines 
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HGF/IFNγ ratio, which ultimately has an impact on differentiation status of normal or 
cancerous breast epithelial cells. While this manuscript was being prepared for 
submission, Picon-Ruiz et al showed that immature and mature adipocytes promote 
cytokine production and drive SRC/SOX2/miR302b-mediated stem cell signaling in 
breast cancer cells (47). However, the study did not investigate adipocyte-derived factors 
involved in promoting cytokine production by cancer cells. It is possible that HGF/IFNγ 
levels might determine to extent to which ASCs/adipocytes influence feed-forward 
cytokine production loop in the breast environment. 
Translation of these findings into clinical practice requires further study.  While 
removal of the tumor is obviously important, reconstructive options to improve quality of 
life gain in meaning as long-term survival increases.  One of the new options is the 
transplantation of adipose tissue augmented with or without ASCs into the breast 
extirpation site.  This current study is the first to show that the ratio of adipocytes and 
ASCs may be a critical influencer of breast cancer cell hierarchy, with some of the 
control over this decision in the hands of the reconstructive surgeon. However, individual 
variations in the ability of ASCs to differentiate to adipocytes, the levels of secreted HGF 
and IFNγ, as well as the genomic aberration status and/or molecular subtypes of any 
residual tumor cells may ultimately determine the safety of ASC/adipocyte 
transplantation. Characterization of ASCs and tumors on an individual basis may help to 
establish safety levels and provide rational guidelines for safer decisions.  
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Figure Legends: 
Figure 1: ASCs increased the size of mammospheres: A) Effects of ASC co-culture on 
the size of mammospheres derived from MCF10A and MCF10A-SRC cells. Both cell 
lines express GFP and GFP-positive spheres were visualized under fluorescent 
microscope. ASCs themselves formed spheres, which were not fluorescent (bottom 
panel). B) ASC CM increased the size of mammospheres. CM from ASC #4 was used in 
this assay. 
 
Figure 2: ASCs increased the number of MCF10A and MCF10A-SLUG cells with 
luminal progenitor features. A) CD49f/EpCAM staining pattern of GFP expressing 
MCF10A cells with or without ASC #4 coculture or CM. Under both conditions, ASCs 
increased CD49f+/EpCAM+ cells (with or without gating for GFP+ cells). B) Results of 
two independent experiments are shown. C) ASC CM increased the size of spheres and 
the luminal progenitor pool of MCF10A-SLUG cells. Image 10X in all figures. Results 
from three independent experiments are shown (right side). 
 
Figure 3: ASCs and adipocytes displayed distinct effects on MCF10A cells: A) Effects of 
ASC and adipocyte CMs on MCF10A-derived mammospheres. Although MCF10A cells 
do not efficiently form the mammospheres, spheres formed in the presence of ASC CMs 
were larger in size. B) ASC CM increased the number of CD44+/CD24- and 
CD49f+/EpCAM- stem cells. Adipocyte CM was less efficient in inducing these changes. 
C) ASC CM was more efficient than adipocyte CM in increasing CD49f+/EpCAM- cells 
in mammospheres. D) ASC CM was more efficient than adipocyte CM in increasing the 
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number of CD44+/CD24- cells in mammospheres. E) ASC and adipocyte CMs did not 
alter CD49f/EpCAM profile of MCF10A cells under 2D culture condition. Cells were 
maintained in DMEM/F12 with 10% FBS for five hours without any supplements, 
switched to serum-free media for 48 hours and then treated with CM for 48 hours. F) 
ASC and adipocyte CMs did not alter the CD44/CD24 profile of MCF10A cells under 2D 
culture condition. 
 
Figure 4: CM from both ASC and adipocytes increased the size of MCF10A-SRC-
derived mammospheres. A) Phase contrast images of mammospheres under three 
conditions (10X). B) CD49f/EpCAM and CD44/CD24 profiles of MCF10A-SRC-derived 
mammospheres under ASC or adipocyte CM-treated conditions. Both ASC and adipocyte 
CMs increased CD49f+/EpCAM+ cells. ASC and adipocyte CMs did not affect CD44 
and CD24 status, as these spheres were predominantly CD44+/CD24-. Results using CM 
from ASC/adipocytes of patient #1 and 2 are shown. C) ASC and adipocyte CMs did not 
alter CD49f/EpCAM status of MCF10A-SRC cells grown under 2D condition. D) 
Adipocyte CM but not ASC CM increased CD44+/CD24- MCF10A-SRC cells grown 
under 2D condition. 
 
Figure 5: CM from ASCs but not adipocytes increased the size of MCF10DCIS.com-
derived mammospheres. A) Phase contrast images of mammospheres under three 
conditions (10X). B) CD44/CD24 and CD49f/EpCAM staining pattern of cells from 
mammospheres. C) ASC CM increased CD49f+/EpCAM+ and CD44+/CD24- cells in 
patient-specific manner. Results of two or more experiments are shown. *p<0.05 Control 
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versus ASC CM-treated condition. D) Adipocyte CM did not alter CD49f/EpCAM 
staining pattern of cells from mammospheres. 
 
Figure 6: HGF and IFNγ had distinct effects on MCF10DCIS.com mammospheres. A) 
Effects of recombinant HGF (50 ng/ml) and IFNγ (50 ng/ml) on MCF10DCIS.com-
derived mammospheres. Mammospheres were treated for 8-10 days with addition of new 
media ± recombinant proteins every three days. B) CD44/CD24 and CD49f/EpCAM 
staining pattern of mammospheres with and without HGF and IFNγ treatment. C) Both 
HGF and IFNγ increased the number of CD49f+/EpCAM+ cells. *p<0.007, control 
versus HGF or IFNγ, **p<0.05 HGF versus IFNγ. D) ASC to adipocyte differentiation 
caused reduction in HGF but an increase in IFNγ. All differences are statistically 
significant. 
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